ATH alterity therapeutics limited

congratulations prana

  1. 5,995 Posts.
    lightbulb Created with Sketch. 162
    You specified executive function and you scored a direct hit.
    Ira Shoulson said from the Alzheimer's results he thought it could help with executive function decline in HD and he was correct.
    This bodes very well for the coming AD results and extension trial. It has helped in brain atrophy, so there is a biomarker to back up the cognition result, and of course it passed the primary endpoint of safety with flying colors.

    Bring on the phase3 and the IMAGINE results.

    Holding through AD results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $82.14M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $28.96K 2.998M

Buyers (Bids)

No. Vol. Price($)
50 17608345 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1358641 4
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.